Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer.

Brockstein B, Samuels B, Humerickhouse R, Arietta R, Fishkin P, Wade J, Sosman J, Vokes EE
Invest New Drugs. 2001 19 (3): 249-54

PMID: 11561683 · DOI:10.1023/a:1010628903248

MeSH Terms (17)

Adult Aged Antineoplastic Agents Bone Neoplasms Bryostatins Carcinoma, Squamous Cell Drug Administration Schedule Female Head and Neck Neoplasms Humans Lactones Macrolides Male Middle Aged Sarcoma Sarcoma Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: